Stability-indicating HPLC method for simultaneous determination of chloramphenicol, dexamethasone sodium phosphate and tetrahydrozoline hydrochloride in ophthalmic solution

13Citations
Citations of this article
46Readers
Mendeley users who have this article in their library.

Abstract

Purpose: A simple stability-indicating RP-HPLC assay method was developed and validated for quantitative determination of Chloramphenicol, Dexamethasone Sodium Phosphate and Tetrahydrozoline Hydrochloride in ophthalmic solution in the presence of 2- amino-1-(4-nitrophenyl)propane-1,3-diol, a degradation product of Chloramphenicol, and Dexamethasone, a degradation product of Dexamethasone Sodium Phosphate. Methods: Effective chromatographic separation was achieved using C18 column (250 mm, 4.6 mm i.d., 5 μm) with isocratic mobile phase consisting of acetonitrile - phosphate buffer (pH 4.0; 0.05 M) (30:70, v/v) at a flow rate of 1 mL/minute. The column temperature was maintained at 40°C and the detection wavelength was 230 nm. Results: The proposed HPLC procedure was statistically validated according to the ICH guideline, and was proved to be stability-indicating by resolution of the APIs from their forced degradation products. Conclusion: The developed method is suitable for the routine analysis as well as stability studies.

Cite

CITATION STYLE

APA

AlAani, H., & Alnukkary, Y. (2016). Stability-indicating HPLC method for simultaneous determination of chloramphenicol, dexamethasone sodium phosphate and tetrahydrozoline hydrochloride in ophthalmic solution. Advanced Pharmaceutical Bulletin, 6(1), 137–141. https://doi.org/10.15171/apb.2016.020

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free